hydroxypropyl-gamma-cyclodextrin has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chono, S; Irie, S; Iwata, K; Ogasawara, A; Tada, H; Togami, K; Yamaguchi, K | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Improvement of the pharmacokinetics and antifibrotic effects of nintedanib by intrapulmonary administration of a nintedanib-hydroxypropyl-γ-cyclodextrin inclusion complex in mice with bleomycin-induced pulmonary fibrosis.
Topics: Animals; Bleomycin; gamma-Cyclodextrins; Idiopathic Pulmonary Fibrosis; Indoles; Mice | 2022 |